Skip to main content
PMC home page
AAPS PharmSci logoLink to AAPS PharmSci
. 2001 Nov 14;3(4):1–18. doi: 10.1208/ps030426

Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance

Susan H Kopleman 1,✉, Larry L Augsburger 1,✉, Agnes NguyenPho 2, William S Zito 3, Fran X Muller 4
PMCID: PMC2751215  PMID: 12049489

Abstract

Objective. The complex composition-activity relationship of botanicals such as St John's Wort (SJW) presents a major challenge to product development, manufacture, and establishment of appropriate quality and performance standards for the formulated products. As part of a larger study aimed at addressing that challenge, the goals of the present study are to (1) determine and compare the phytochemical profiles of 3 commercial SJW extracts; (2) assess the possible impact of humidity, temperature, and light on their stability; and (3) evaluate several physical properties important to the development of solid dosage forms for these extracts. Methods. An adapted analytical method was developed and validated to determine phytochemical profiles and assess their stability. The extract physical properties measured were particle size (Malvern Mastersizer), flow (Carr's compressibility index; minimum orifice diameter), hygroscopicity (method of Callahan et al), and low-pressure compression physics (method of Heda et al). Results. The phytochemical properties differed greatly among the extracts and were extremely sensitive to changes in storage conditions, with marked instability under conditions of elevated humidity. All extracts exhibited moderate to free-flow properties and were very hygroscopic. Compression properties varied among the extracts and differed from a common use excipient, microcrystalline cellulose. Conclusions. Three commercial sources of SJW extracts exhibited different physical and chemical properties. Standardization to 1 or 2 marker compounds does not ensure chemical equivalence nor necessarily equivalent pharmacological activity. Flow and compression properties appear suitable for automatic capsule-filling machines, but hydroscopicity and the moisture sensitivity of the phytochemical profile are concerns.

Keywords: Hypericum perforatum, St John's Wort, Nutraceuticals

References

  • 1.Barnes J, Anderson LA, Phillipson D. St. John's Wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001;53(5):583–600. doi: 10.1211/0022357011775910. [DOI] [PubMed] [Google Scholar]
  • 2.Consumer safety symposium on dietary supplements and herbs [press release]. New York: Good Housekeeping Institute; March 3, 1998.
  • 3.Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Sys Pharm. 2000;57:963–969. doi: 10.1093/ajhp/57.10.963. [DOI] [PubMed] [Google Scholar]
  • 4.Cui J, Garle M, Eneroth P, Bjorkhem I. What do commercial ginseng preparations contain? Lancet. 1994;344(8915):134–134. doi: 10.1016/S0140-6736(94)91322-6. [DOI] [PubMed] [Google Scholar]
  • 5.Herbal Rx-the promises and the pitfalls. Cons Rep. 1999;May:44–48. [PubMed]
  • 6.Kopelman SH, Augsburger LL. Some Physical Properties of Ginkgo biloba Extracts Important for Tableting and Encapsulation. JANA. 2000;3(2):32–37. [Google Scholar]
  • 7.Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. Flavonoids from Hypericum peforatum show antidepressant activity in the forced swimming test. Planta Med. 2000;66(1):3–6. doi: 10.1055/s-2000-11119. [DOI] [PubMed] [Google Scholar]
  • 8.Sparenberg B, Demisch L, Holzl J. Investigations of the antidepressive effects of St. John's wort. Pz Wissenschaft. 1993;138(2):50–54. [Google Scholar]
  • 9.Calapai G, Crupi A, Firenzuoli F, et al. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J Pharm Pharmacol. 1999;51(6):723–728. doi: 10.1211/0022357991772862. [DOI] [PubMed] [Google Scholar]
  • 10.Calapai G, Crupi A, Firenzuoli F, et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry. 2001;34(2):45–49. doi: 10.1055/s-2001-15180. [DOI] [PubMed] [Google Scholar]
  • 11.Sloley BD, Urichuk LJ, Ling L, et al. Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol. Sin. 2000;21(12):1145–1152. [PubMed] [Google Scholar]
  • 12.Chatterjee SS, Noldner M, Koch M, Erdelmeier C. Antidepressant activity of Hypercium perforatum L. and hyperforin, the neglected possibility. Pharmacopsychiatry. 1998;31(1):7–15. doi: 10.1055/s-2007-979340. [DOI] [PubMed] [Google Scholar]
  • 13.Lavie G, Mazur Y, Lavie D, et al. Hypericin as an inactivator of infectious viruses in blood components. Transfusion. 1995;35(5):392–400. doi: 10.1046/j.1537-2995.1995.35595259149.x. [DOI] [PubMed] [Google Scholar]
  • 14.Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci. 1998;63(6):499–510. doi: 10.1016/S0024-3205(98)00299-9. [DOI] [PubMed] [Google Scholar]
  • 15.Laakmann G, Schule C, Baghai T, Kieser M. St. John's Wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 1998;31:54–59. doi: 10.1055/s-2007-979346. [DOI] [PubMed] [Google Scholar]
  • 16.Melzer M, Fuhrken D, Kolkmann R. Hyperforin in St. John's Wort: main active principle or only a key substance? Deut Apoth Zeitung. 1998;138(December):56–62. [Google Scholar]
  • 17.Hypericum perforatum constituent identification by HPLC. 104.000. Denver, CO: Institute for Nutraceutical Advancement; 2000. [Google Scholar]
  • 18.Brolis M, Gabetta B, Fuzzati N, et al. Identification of high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J Chromatogr A. 1998;825:9–16. doi: 10.1016/S0021-9673(98)00697-9. [DOI] [Google Scholar]
  • 19.Bilia AR, Bergonzi MC, Morgenni F, et al. Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int J Pharm. 2001;213:199–208. doi: 10.1016/S0378-5173(00)00660-8. [DOI] [PubMed] [Google Scholar]
  • 20.Determination of hypericin and pseudohypericin in St. John's Wort by high-performance liquid chromatography. 107.000. Denver, CO: Institute for Nutraceutical Advancement; 2000. pp. 1–4. [Google Scholar]
  • 21.Determination of hyperforin in St. John's Wort extract and plant material by high-performance liquid chromatography. 112.000. Denver, CO: Institute for Nutraceutical Advancement; 2000. pp. 1–4. [Google Scholar]
  • 22.Maisenbacher P, Kovar KA. Analysis and stability of hyperici oleum. Planta Med. 1992;58(4):351–354. doi: 10.1055/s-2006-961483. [DOI] [PubMed] [Google Scholar]
  • 23.Orth HCJ, Schmidt PC. Stability and stabilization of hyperforin. Pharm. Ind. 2000;62(1):60–63. [Google Scholar]
  • 24.Fourneron J, Herbette G, Caloprisco E. Pseudohypericin and hypericin in St. John's Wort extracts. Breakdown of pseudohypericin. Comptes Rendes de L'Academie des Sciences Serie II Fascicule G-Chimie. 1999;2(3):127–131. doi: 10.1016/S1251-8069(99)80024-3. [DOI] [Google Scholar]
  • 25.Carr RL. Particle behavior, storage, and flow. Brit Chem Eng. 1970;15:1541–1549. [Google Scholar]
  • 26.The United States Pharmacopeia-Pharmacopeial Forum. 24th ed. Rockville, MD: U S Pharmacopeial Convention, Inc.; 1998. Physical tests and determinations-bulk density and tapped density; pp. 6569–6570. [Google Scholar]
  • 27.Gioia A. Intrinsic flowability: a new technology for powder flowability classification. Pharm Technol. 1980;February:65–68. [Google Scholar]
  • 28.Callahan JC, Cleary GW, Elefant M, et al. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm. 1982;8(3):355–369. doi: 10.3109/03639048209022105. [DOI] [Google Scholar]
  • 29.Heda PK, Muller FX, Augsburger LL. Capsule filling machine simulation. Part 1. Low-force powder compression physics relevant to plug formation. Pharm Dev Tech. 1999;4(2):209–219. doi: 10.1081/PDT-100101355. [DOI] [PubMed] [Google Scholar]
  • 30.Shah K. The influence of important mechine operating variables on slug formation, fill weight, and drug release from a dosing disc type automatic capsule filling machine. Baltimore, MD: University of Maryland; 1986. [Google Scholar]
  • 31.Nelson E, Naqvi SM, Busse LW, Higuchi T. Physics of tablet compression IV. Relationship of ejection and upper and lower punch forces during the compressional process: application of measurements to comparison of tablet lubricants. J Am Pharm Assoc Sci Ed. 1954;43:596–602. [PubMed] [Google Scholar]
  • 32.Shaxby JH, Evans JC. The variation of presure with depth in columns of powders. Trans Faraday Soc. 1923;19:60–72. doi: 10.1039/tf9231900060. [DOI] [Google Scholar]
  • 33.Heckel RW. Density-pressure relationships in powder compression. Trans Metall Soc A I M E. 1961;221:671–675. [Google Scholar]
  • 34.Kawakita K, Ludde K.H. Some considerations on powder compression equations. Powder Technol. 1970;4:61–68. doi: 10.1016/0032-5910(71)80001-3. [DOI] [Google Scholar]
  • 35.Augsburger LL. Hard and soft shell capsules. In: Banker G, Rhodes CT, editors. Modern Pharmaceutics. New York: Marcel Dekker, Inc; 1995. pp. 441–490. [Google Scholar]
  • 36.Kontny MJ, Mulski CA. Gelatin capsule brittleness as a function of relative humidity at room temperature. Int J Pharm. 1989;54:79–85. doi: 10.1016/0378-5173(89)90168-3. [DOI] [Google Scholar]
  • 37.Bell JH, Stevenson NA, Taylor JE. A moisture transfer effect in hard gelatin capsules of sodium cromoglycate. J Pharm Pharmacol. 1973;25:96P–103P. [PubMed] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES